Yeju Medical (06929): Completed the acquisition of 100% of the shares of Italian distributor MC Health

Zhitong Finance App News, Yeju Medical (06929) announced that the company completed the acquisition (transaction) of 100% of the shares (transaction) of Italian distributor McHealth S.r.l. (MC Health) on October 15, 2026.

With the completion of the transaction, McHealth became a wholly-owned subsidiary of the Group.

The number of cutaneous coronary artery interventions in Italy is around 157,000 per year, making it one of the major markets for interventional cardiovascular treatment in Europe. With this acquisition, the Group switched its local business to a direct sales model. In addition to deepening customer relationships and improving market adaptability, it can also tap the growth potential of its leading industry's coronary product portfolio. Once the acquisition is completed, the Group can immediately launch direct sales business through MC Health covering cardiac catheterization centers in Italy.

Since its listing in Hong Kong in 2022, the company has been working to accelerate the expansion of its global direct sales network. Among them, the Group successively acquired dealers in Indonesia and Taiwan in 2023 and 2025, injecting growth momentum into the Asia-Pacific region and marking an important milestone in the direct sales transformation strategy. With the addition of the Italian market to the direct sales network, along with direct sales teams established in the Netherlands, Belgium and Luxembourg earlier this year, the Group will not only further consolidate its European business footprint, but will also lay a solid foundation for long-term sustainable development through 16 direct sales markets around the world.